https://adisinsight.springer.com/drugsafety/803903283?error=cookies_not_supported&code=4697064d-ded0-4ed8-86f2-1003b7b03873
Orelabrutinib - AdisInsight
In a retrospective study involving 19 patients, a patient [age and sex not stated] was described, who developed grade 3 haematological disorder during treatment
orelabrutinib